|
Amersham Biosciences helps scientists and drugmakers blaze new trails in the biosciences. The company, a subsidiary of Amersham (itself now part of GE), is a leading supplier of equipment and services for biotechnology research and drug development. The firm's products include MegaBACE DNA sequencers; chromatographic systems to purify proteins; protein-labeling systems; and assays. Amersham Biosciences' customers include corporations, universities, and research institutes. The company's genomics business is based in the US, while its proteomics and separations operations are in Sweden, and its bioassays unit is in the UK.
|
| | | Contact Information | |
Address: |
Amersham Place
Little Chalfont, Buckinghamshire HP7 9NA, United Kingdom
| | Phone: | +44-0870-606-1921 | | Fax: | +44-0149-454-4350 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2002): | 1075.40 M | | Revenue Growth (1 yr): | 8.90% | | Employees (2002): | 4,650 | | Employee Growth (1 yr): | 5.70% |
|
|
Key People
| | • |
CEO:
Andrew Carr
| | • |
CFO:
Sandra Cartie
| | • |
CTO:
Michael (Mike) Hayes
|
|
|
